Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
SPRY —
ARS PHARMACEUTICALS INC
CUSIP: 82835W108 · Held by 2 superinvestors · Combined value: $30,256,320
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $23,776,159 | 2,040,872 | ADD | +311,739 |
| 2 | Dan Loeb | 0.1% | $6,480,161 | 556,237 | NEW BUY | +556,237 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Dan Loeb | NEW BUY | +556,237 | New |
| Ken Griffin | ADD | +311,739 | +18.0% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | REDUCE | -629,843 | -26.7% |
Who Owns SPRY? Superinvestor Holdings
ARS PHARMACEUTICALS INC is held by 2 tracked superinvestors, with a combined position value of $30 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Dan Loeb (0.1% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.